VedaBio is a startup based in the United States, most recent round Series A, 1 tracked investor.
VedaBio is a startup based in the United States. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
VedaBio develops a CRISPR-based molecular detection platform that enables ultra-rapid, amplification-free, and highly multiplexed nucleic acid detection for diagnostics applications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.